Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the FDA warned Wednesday.
from WebMD Health https://www.webmd.com/hepatitis/news/20190829/fda-warns-of-liver-problems-for-some-taking-hep-c-drugs?src=RSS_PUBLIC
0 Comments:
Post a Comment